ICL
NYSE · Chemicals
Icl Group Ltd
$5.40
+0.06 (+1.12%)
Financial Highlights (FY 2026)
Revenue
22.30B
Net Income
704.49M
Gross Margin
30.6%
Profit Margin
3.2%
Rev Growth
-10.6%
D/E Ratio
0.46
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 30.6% | 30.6% | 37.4% | 37.4% |
| Operating Margin | 8.1% | 7.3% | 17.6% | 17.0% |
| Profit Margin | 3.2% | 3.0% | 18.0% | 15.1% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 22.30B | 24.94B | 7.12B | 6.72B |
| Gross Profit | 6.81B | 7.62B | 2.66B | 2.51B |
| Operating Income | 1.81B | 1.82B | 1.25B | 1.14B |
| Net Income | 704.49M | 709.30M | 1.28B | 1.02B |
| Gross Margin | 30.6% | 30.6% | 37.4% | 37.4% |
| Operating Margin | 8.1% | 7.3% | 17.6% | 17.0% |
| Profit Margin | 3.2% | 3.0% | 18.0% | 15.1% |
| Rev Growth | -10.6% | -10.6% | +21.5% | +18.9% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 3.40B | 3.40B | 3.42B | 3.02B |
| Total Equity | 7.39B | 7.39B | 10.49B | 11.64B |
| D/E Ratio | 0.46 | 0.46 | 0.33 | 0.26 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 3.73B | 3.96B | 1.79B | 1.80B |
| Free Cash Flow | — | — | 781.09M | 495.76M |